Literature DB >> 11677116

Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells.

H K Yi1, P H Hwang, D H Yang, C W Kang, D Y Lee.   

Abstract

Insulin-like growth factor (IGF)-I and -II are potent mitogens and postulated to exert autocrine, and paracrine effects on growth regulation in human gastric cancer. Their mitogenic effects are tightly regulated by the IGF binding proteins (IGFBPs). In this study, we evaluated the mRNA expression of IGF-I, IGF-II and the IGFBPs in a panel of human gastric cancer cell lines, and normal and tumour tissue specimens from patients with gastric cancer by reverse transcriptase-polymerase chain reaction (RT-PCR) and competitive PCR. Conditioned media (CM) of the gastric cancer cell lines were studied for the secretion of the IGFBPs by western ligand blot (WLB) and western immunoblot (WIB). IGF-I and IGF-II were expressed in all of the gastric cancer cell lines, and the normal and tumour tissue specimens. Overexpression of the IGFs, in particular, IGF-II, was observed in the tumour tissues. The expression pattern of IGFBPs was heterogeneous among the gastric cancer cell lines. IGFBP-2 was expressed in all of the gastric cancer cell lines, whereas IGFBP-1 was not detected in any cell lines. IGFBP-4 was expressed in the most of cell lines. IGFBP-3, IGFBP-5 and IGFBP-6 were expressed in approximately 50% of cell lines. In addition, exogenous IGF-I and IGF-II stimulated the proliferation of gastric cancer cells, suggesting the existence of a functional IGF system in gastric cancer. Taken together, our data-suggest that the IGF-IGFBP system may play an important role in the initiation, progression and metastasis of gastric cancer. Further studies are needed to understand the exact role of IGFs and IGFBPs in gastric neoplasia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677116     DOI: 10.1016/s0959-8049(01)00269-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  35 in total

1.  Selective gene expression by rat gastric corpus epithelium.

Authors:  M Goebel; A Stengel; N W G Lambrecht; G Sachs
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

2.  Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.

Authors:  Subhalakshmi Ganguly; Biswarup Basu; Saurav Shome; Tushar Jadhav; Sudipta Roy; Jahar Majumdar; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Am J Pathol       Date:  2010-11-12       Impact factor: 4.307

3.  Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population.

Authors:  Li-Na Mu; Qing-Yi Lu; Shun-Zhang Yu; Qing-Wu Jiang; Wei Cao; Nai-Chieh You; Veronica Wendy Setiawan; Xue-Fu Zhou; Bao-Guo Ding; Ru-Hong Wang; Jinkou Zhao; Lin Cai; Jian-Yu Rao; David Heber; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2005-10-10       Impact factor: 7.396

4.  Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells.

Authors:  Min Sun Kim; Dae-Yeol Lee
Journal:  Mol Cell Biochem       Date:  2015-02-07       Impact factor: 3.396

5.  RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation.

Authors:  Baisong Liao; Yan Hu; Gary Brewer
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

6.  Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo.

Authors:  M B Resnick; E Sabo; P A Meitner; S S Kim; Y Cho; H K Kim; R Tavares; S F Moss
Journal:  Gut       Date:  2006-04-26       Impact factor: 23.059

7.  Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts.

Authors:  Y Min; Y Adachi; H Yamamoto; A Imsumran; Y Arimura; T Endo; Y Hinoda; C-T Lee; S Nadaf; D P Carbone; K Imai
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 8.  Diabetes and gastric cancer: the potential links.

Authors:  Chin-Hsiao Tseng; Farn-Hsuan Tseng
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

9.  Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation.

Authors:  Liang-Hui Shi; Xiao-Qun Zhu; Guo-Hai Zhao; Ya-Bin Xia; Yi-Sheng Zhang
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

10.  Prognostic value of tumor-related molecular expression in gastric carcinoma.

Authors:  Zhong-Sheng Zhao; Yuan-Yu Wang; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Pathol Oncol Res       Date:  2009-03-18       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.